المؤلفون: Mozetic V; Ophthalmologist of Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil., Leonel L; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil., Leite Pacheco R; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil. rleitepacheco@hotmail.com.; Centro Universitário São Camilo, São Paulo, Brazil. rleitepacheco@hotmail.com., de Oliveira Cruz Latorraca C; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil., Guimarães T; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil., Logullo P; EQUATOR Network, NDORMS, Oxford University, Oxford, UK., Riera R; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil.; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil.

المصدر: Trials [Trials] 2019 Dec 16; Vol. 20 (1), pp. 729. Date of Electronic Publication: 2019 Dec 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Data Accuracy*, Checklist/*standards , Diabetic Retinopathy/*drug therapy , Fibric Acids/*therapeutic use , Guideline Adherence/*standards , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Randomized Controlled Trials as Topic/*standards , Research Design/*standards, Diabetic Retinopathy/diagnosis ; Fibric Acids/adverse effects ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Treatment Outcome

المؤلفون: Taís Guimarães, Rafael Leite Pacheco, Rachel Riera, Carolina de Oliveira Cruz Latorraca, Patricia Logullo, Vânia Mozetic, Letícia de Freitas Leonel

المصدر: Trials, Vol 20, Iss 1, Pp 1-6 (2019)
Trials

مصطلحات موضوعية: medicine.medical_specialty, Blinding, Randomization, Medicine (miscellaneous), Publication bias, Hydroxymethylglutaryl-CoA reductase inhibitors, law.invention, 03 medical and health sciences, Clinical trials as topic, 0302 clinical medicine, Randomized controlled trial, Interquartile range, law, Hypolipidemic agents, Diabetic retinopathy, Humans, Medicine, Pharmacology (medical), 030212 general & internal medicine, Randomized Controlled Trials as Topic, lcsh:R5-920, business.industry, Research, Fibric Acids, Consolidated Standards of Reporting Trials, Checklist, Data Accuracy, Critical appraisal, Treatment Outcome, Research Design, 030221 ophthalmology & optometry, Physical therapy, Guideline Adherence, business, lcsh:Medicine (General)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8cb77ad81304fadce7c5fdc6dc9796
https://doaj.org/article/e113fb34f3854e5f82a804223792a31d